With a combined population of nearly 200 million people across Russia, the Ukraine, Estonia, Latvia and Lithuania, this group of countries offers a highly competitive recruitment environment for clinical trials. Furthermore, the following advantages are just some of the reasons why this region makes a favourable addition to any country mix:
• Highly motivated and GCP trained Investigators
• Good quality and reliable data
• Huge recruitment potential for rare diseases (many treatment naive)
• Good patient compliance with low drop-out rates
• Diversity of disease prevalence including cardiology, oncology, respiratory and endocrinology
• Cost savings over Western European countries
Orphan Reach can help you to navigate the regulatory and logistical requirements in these countries and to ultimately benefit from the advantages this region has to offer.